Ziff Davis Reports Mixed Q4 & FY25 Results, Defers Guidance Amid Strategic Review, Repurchases $174M in Stock

summarizeSummary

Ziff Davis reported mixed Q4 and full-year 2025 results, with GAAP net income significantly impacted by a $58 million loss on a business sale, and deferred 2026 guidance amid a strategic review, while also executing substantial share repurchases.

check_boxKey Events

• Q4 2025 Financial Performance

  GAAP net income plummeted to $0.4 million ($0.01 diluted EPS) from $64.1 million ($1.43 diluted EPS) in Q4 2024, primarily due to a $58.0 million loss on sale of business and a $19.7 million loss on equity method investment. Revenues slightly decreased by 1.5% to $406.7 million, while Adjusted EBITDA decreased 5.0% and Adjusted diluted EPS decreased 0.8%.

• Full Year 2025 Financial Performance

  Full-year revenues increased 3.5% to $1.45 billion, Adjusted EBITDA increased 0.3%, and Adjusted diluted EPS increased 0.2%. However, GAAP net income decreased 24.8% to $47.4 million ($1.15 diluted EPS), significantly impacted by the $58.0 million loss on sale of business.

• Guidance Deferral Amid Strategic Review

  The company deferred its fiscal 2026 guidance, citing an ongoing strategic review of value-creating opportunities, including the potential sale of entire divisions. This was previously noted in the Q3 2025 earnings release.

• Significant Share Repurchases

  Ziff Davis repurchased $173.8 million of its common stock during 2025, including $60.6 million in Q4. The CEO stated this was done with the conviction that the share price does not adequately reflect the intrinsic value of the businesses, especially as the stock trades near its 52-week low.

auto_awesomeAnalysis

The filing presents a mixed financial picture for Ziff Davis. While full-year adjusted metrics showed modest growth and free cash flow remained strong, GAAP net income and diluted EPS for both Q4 and the full year were severely impacted by a significant $58.0 million loss on the sale of a business and other one-time charges. This substantial non-recurring loss will likely overshadow the underlying operational performance in the short term. The decision to defer fiscal 2026 guidance, linked to an ongoing strategic review that includes potential division sales, introduces considerable uncertainty about the company's future structure and financial outlook. However, management demonstrated strong conviction by repurchasing $173.8 million in shares during 2025, explicitly stating their belief that the stock is undervalued, especially as it trades near its 52-week low. Investors will need to weigh the impact of these one-time losses and future uncertainty against the company's cash generation and management's confidence in its valuation.